We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $397M
1-Year Est. Return 178.66%
This Fund
S&P 500
This Quarter Est. Return
+14.89%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$175M
AUM Growth
-$24.6M
Cap. Flow
-$44.2M
Cap. Flow %
-25.23%
Top 10 Hldgs %
18.84%
Holding
121
New
32
Increased
14
Reduced
45
Closed
30

Sector Composition

Rank Sector Weight
1 Technology 23.14%
2 Healthcare 20.48%
3 Consumer Discretionary 18.51%
4 Industrials 10.93%
5 Financials 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDXG icon
76
MiMedx Group
MDXG
$622M
$1.25M 0.71%
120,440
-94,936
-44% -$889K
RICE
77
DELISTED
Rice Energy Inc.
RICE
$1.22M 0.7%
56,121
-27,455
-33% -$521K
CRZO
78
DELISTED
Carrizo Oil & Gas Inc
CRZO
$1.21M 0.69%
+24,370
New +$1.14M
TXTR
79
DELISTED
TEXTURA CORPORATION COM
TXTR
$1.14M 0.65%
+41,950
New +$1.11M
AFAM
80
DELISTED
Almost Family Inc
AFAM
$1.13M 0.65%
+25,300
New +$847K
DWRE
81
DELISTED
DEMANDWARE INC COM STK (DE)
DWRE
$1.13M 0.64%
18,470
-4,085
-18% -$238K
CLVS
82
DELISTED
Clovis Oncology, Inc.
CLVS
$1.1M 0.63%
+14,780
New +$1.04M
LRMR icon
83
Larimar Therapeutics
LRMR
$413M
$939K 0.54%
1,976
-2,731
-58% -$1.3M
FNGN
84
DELISTED
Financial Engines, Inc.
FNGN
$932K 0.53%
+22,285
New +$879K
HUBS icon
85
HubSpot
HUBS
$12.3B
$910K 0.52%
22,795
+6,670
+41% +$249K
RDUS
86
DELISTED
Radius Health, Inc.
RDUS
$857K 0.49%
+20,810
New +$935K
HURN icon
87
Huron Consulting
HURN
$2.39B
$755K 0.43%
+11,410
New +$801K
AKRX
88
DELISTED
Akorn Inc
AKRX
$692K 0.39%
+14,555
New +$661K
NBIX icon
89
Neurocrine Biosciences
NBIX
$16.9B
$691K 0.39%
+17,410
New +$623K
PTLA
90
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$585K 0.33%
+15,405
New +$529K
TBHC
91
DELISTED
The Brand House Collective
TBHC
$548K 0.31%
23,070
-21,205
-48% -$508K
AVDL
92
DELISTED
Avadel Pharmaceuticals
AVDL
-123,603
Closed -$2.12M
BLUE
93
DELISTED
bluebird bio
BLUE
-973
Closed -$1.16M
HQY icon
94
HealthEquity
HQY
$8.72B
-60,804
Closed -$1.55M
INGN icon
95
Inogen
INGN
$182M
-60,365
Closed -$1.89M
IONS icon
96
Ionis Pharmaceuticals
IONS
$9.06B
-36,805
Closed -$2.27M
LPSN icon
97
LivePerson
LPSN
$22.1M
-3,276
Closed -$693K
MPAA icon
98
Motorcar Parts of America
MPAA
$257M
-45,597
Closed -$1.42M
SAIA icon
99
Saia
SAIA
$9.61B
-26,768
Closed -$1.48M
SNCR
100
DELISTED
Synchronoss Technologies
SNCR
-2,529
Closed -$953K

Similar funds

Lisanti Capital Growth's Q1 2015 Portfolio in Review

As of Q1 2015, Lisanti Capital Growth held 121 positions worth $175M, down 12% from $200M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Lisanti Capital Growth withdrew a net $44.2M in Q1 2015, closing 30 positions and reducing 45 holdings. Its most notable exit was NuVasive, Inc., an estimated $4.09M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Lisanti Capital Growth opened a new position in LendingTree worth $3.12M.

  • Lisanti Capital Growth's largest Q1 2015 buy was LendingTree: 55,640 shares worth $3.12M.
  • Lisanti Capital Growth added most to Sleep Number in Q1 2015, an estimated $1.38M increase.
  • Lisanti Capital Growth's biggest Q1 2015 reduction was Acadia Healthcare, cutting an estimated $3.34M.
  • Lisanti Capital Growth fully exited NuVasive, Inc. in Q1 2015, selling an estimated $4.09M.
  • Lisanti Capital Growth's ten largest holdings make up 19% of its $175M portfolio in Q1 2015.
  • Lisanti Capital Growth opened 32 new positions and closed 30 in Q1 2015.
  • Lisanti Capital Growth's portfolio value fell 12% quarter-over-quarter to $175M.

Based on Lisanti Capital Growth's 13F filing for Q1 2015, filed 13 May 2015.